RxDoctor Payments Data

Nicole Overbeck, PA

Physician Assistant · Cincinnati, OHNPI 1376724047

Payments from drug & device makers

$3,088in general payments, 2019–2025

Across 167 payments — averaging $18.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$640
  • AstraZeneca$376
  • Bayer$341
  • Idorsia Pharmaceuticals US Inc$247
  • Lilly USA, LLC$220
  • Otsuka America Pharmaceutical, Inc.$219
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,088100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,088 in reported general payments places this provider in the 90th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$10,098
Medicare patients
58
Services billed
146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$33,713
ProliaDenosumab11$19,245
JardianceEmpagliflozin17$16,980
MounjaroTirzepatide13$16,612
FarxigaDapagliflozin Propanediol12$13,305
Aripiprazole14$693
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide22$670
Raloxifene Hcl13$645
Omeprazole48$576
Atorvastatin Calcium102$490
Bupropion XlBupropion Hcl26$423
Albuterol Sulfate HfaAlbuterol Sulfate20$423
Ursodiol11$391
Sertraline Hcl43$362
Escitalopram Oxalate27$320

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$87$33,71331 claims
AmgenProlia$15$19,24511 claims
Boehringer IngelheimJardiance$32$16,98017 claims
Lilly USA, LLCMounjaro$220$16,61213 claims
AstraZenecaFarxiga$376$13,30512 claims
AbbVieSynthroid$640$14113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →